Sulav Duwal
Berlin, BE, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
NT-proBNP Qualifies as a Surrogate for Clinical End Points in Heart Failure.
Journal: Clinical pharmacology and therapeutics
Published: September 08, 2020
The Utility of Efavirenz-based Prophylaxis Against HIV Infection. A Systems Pharmacological Analysis.
Journal: Frontiers in pharmacology
Published: December 14, 2018
Hybrid stochastic framework predicts efficacy of prophylaxis against HIV: An example with different dolutegravir prophylaxis schemes.
Journal: PLoS computational biology
Published: December 22, 2017
Mechanistic framework predicts drug-class specific utility of antiretrovirals for HIV prophylaxis.
Journal: PLoS computational biology
Published: December 22, 2017
Multiscale Systems-Pharmacology Pipeline to Assess the Prophylactic Efficacy of NRTIs Against HIV-1.
Multiscale Systems-Pharmacology Pipeline to Assess the Prophylactic Efficacy of NRTIs Against HIV-1.
Journal: CPT: pharmacometrics & systems pharmacology
Published: April 29, 2016
Top-down and bottom-up modeling in system pharmacology to understand clinical efficacy: An example with NRTIs of HIV-1.
Journal: European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences
Published: September 08, 2015
Optimal Treatment Strategies in the Context of 'Treatment for Prevention' against HIV-1 in Resource-Poor Settings.
Journal: PLoS computational biology
Published: June 17, 2014
Pharmacokinetics and pharmacodynamics of the reverse transcriptase inhibitor tenofovir and prophylactic efficacy against HIV-1 infection.
Journal: PloS one
Published: March 02, 2012
Showing 1-8 of 8
Last Updated: 09/26/2026